Earnings History Data for Ocular Therapeutix, Inc. (OCUL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2024	PM		OCUL	Ocular Therapeutix, Inc.	1,650	-0.26	-0.23	-0.51	Ocular Therapeutix GAAP EPS of -$0.22 beats by $0.02, revenue of $15.43M misses by $1.71M [11/14/2024 7:09 AM]	9.91	-0.69 (-6.51%)	10.55	-0.05 (-0.47%)	2.05 - 11.77	1,234,302	840,000	4,266
Ocular Therapeutix Q3 2024 Earnings Preview [11/13/2024 2:09 PM] Ocular Therapeutix GAAP EPS of -$0.22 beats by $0.02, revenue of $15.43M misses by $1.71M [11/14/2024 7:09 AM] Ocular Therapeutix Reports Third Quarter 2024 Results and Business Highlights [2024-11-14 07:00AM] Ocular Therapeutix to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV [Nov-13-24 07:30AM] What To Expect From Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings [Nov-13-24 07:17AM]
07-08-2024	PM		OCUL	Ocular Therapeutix, Inc.	1,210	-0.24	-0.22	-0.27	Ocular Therapeutix GAAP EPS of -$0.26 misses by $0.04, revenue of $16.44M beats by $0.59M [8/7/2024 7:15 AM]	8.32	0.43 (5.51%)	8.30	0.41 (5.20%)	2.00 - 11.31	1,893,454	1,010,000	6,850
Ocular Therapeutix Q2 2024 Earnings Preview [8/6/2024 12:11 PM] Ocular Therapeutix GAAP EPS of -$0.26 misses by $0.04, revenue of $16.44M beats by $0.59M [8/7/2024 7:15 AM] Ocular says FDA views Phase 3 study as appropriate to support NDA [8/7/2024 11:31 AM]
07-05-2024	AH		OCUL	Ocular Therapeutix	955.00	-0.24	-0.18	0.00	Ocular Therapeutix GAAP EPS of -$0.49 misses by $0.29, revenue of $14.77M misses by $0.59M [5/7/2024 4:35 PM]	5.75	-0.18 (-3.12%)	5.80	-0.13 (-2.19%)	2.00 - 11.31	2,371,803	3,760,000	3,473
Ocular Therapeutix GAAP EPS of -$0.49 misses by $0.29, revenue of $14.77M misses by $0.59M [5/7/2024 4:35 PM]
11-03-2024	AH		OCUL	Ocular Therapeutix, Inc.	823.57	-0.28	-0.28	-0.24	Ocular Therapeutix GAAP EPS of -$0.35 misses by $0.05, revenue of $14.8M misses by $0.91M [3/11/2024 4:10 PM]	9.31	-0.42 (-4.32%)	9.65	-0.08 (-0.82%)	2.00 - 11.31	3,008,830	2,480,000	72,396
Biggest stock movers today: EQT, MESO, Crypto-linked stocks, and more [3/11/2024 9:47 AM] Ocular Therapeutix GAAP EPS of -$0.35 misses by $0.05, revenue of $14.8M misses by $0.91M [3/11/2024 4:10 PM]
07-11-2023	AH		OCUL	Ocular Therapeutix, Inc.	258.80	-0.51	-0.27	-0.30	Ocular Therapeutix GAAP EPS of -$0.25 beats by $0.04, revenue of $15.08M misses by $0.08M [11/7/2023 4:04 PM]	2.46	-0.38 (-13.20%)	2.65	-0.19 (-6.69%)	2.23 - 7.96	1,153,562	1,340,000	964
Ocular Therapeutix GAAP EPS of -$0.25 beats by $0.04, revenue of $15.08M misses by $0.08M [11/7/2023 4:04 PM] Ocular Therapeutix files for $300M mixed shelf [11/7/2023 5:54 PM]
07-08-2023	AH		OCUL	Ocular Therapeutix, Inc.	341.88	-0.27	-0.29	-0.28	Ocular Therapeutix GAAP EPS of -$0.26 beats by $0.04, revenue of $15.19M beats by $0.54M [8/7/2023 4:26 PM]	3.85	-0.52 (-11.81%)	4.01	-0.35 (-8.03%)	2.57 - 7.96	1,861,347	650,000	9,805
Ocular Therapeutix GAAP EPS of -$0.26 beats by $0.04, revenue of $15.19M beats by $0.54M [8/7/2023 4:26 PM]
08-05-2023	AH	4:00 PM ET (May 8)	OCUL	Ocular Therapeutix, Inc.	472.03	-0.31	-0.27	-0.22	Ocular Therapeutix GAAP EPS of -$0.39 misses by $0.12, revenue of $13.37M misses by $0.73M [5/8/2023 4:23 PM]	6.54	0.14 (2.19%)	6.59	0.19 (2.97%)	2.57 - 6.86	1,731,812	830,000	4,583
Ocular Therapeutix GAAP EPS of -$0.39 misses by $0.12, revenue of $13.37M misses by $0.73M [5/8/2023 4:23 PM]
06-03-2023	AH	4:00 PM ET (Mar 6)	OCUL	Ocular Therapeutix, Inc.	466.68	-0.24	-0.25	-0.23	Ocular Therapeutix Q4 GAAP EPS, revenue beats, guidance below consensus [3/6/2023 4:04 PM]	5.87	0.29 (5.11%)	5.95	0.37 (6.63%)	2.57 - 6.53	1,786,335	1,220,000	48,447
Ocular Therapeutix Q4 GAAP EPS, revenue beats, guidance below consensus [3/6/2023 4:04 PM] Ocular Therapeutix stock rises after posting Q4 results beat, strong guidance [3/7/2023 3:39 PM]
07-11-2022	AH	4:00 PM ET (Nov 7)	OCUL	Ocular Therapeutix, Inc.	274.77	-0.30	-0.23	-0.23	Ocular Therapeutix GAAP EPS of -$0.31 misses by $0.07, revenue of $11.97M misses by $2.3M [11/7/2022 4:03 PM]	3.16	-0.39 (-10.99%)	3.60	0.05 (1.41%)	2.91 - 7.86	1,770,949	610,000	1,328
Ocular Therapeutix GAAP EPS of -$0.31 misses by $0.07, revenue of $11.97M misses by $2.3M [11/7/2022 4:03 PM] Ocular falls 12% as eye therapy Dextenza Q3 sales decline, cuts FY22 outlook [11/8/2022 12:56 PM] Ocular Therapeutix hits 52-week low after slashing revenue guidance [11/8/2022 1:13 PM]
08-08-2022	AH	4:00 PM ET (Aug 8)	OCUL	Ocular Therapeutix, Inc.	335.44	-0.28	-0.23	-0.25	Ocular Therapeutix GAAP EPS of -$0.25 misses by $0.02, revenue of $12.26M misses by $1.99M [8/8/2022 4:02 PM]	4.89	-0.17 (-3.36%)	5.00	-0.06 (-1.19%)	2.91 - 12.50	904,370	420,000	9,877
Ocular Therapeutix GAAP EPS of -$0.25 misses by $0.02, revenue of $12.26M misses by $1.99M [8/8/2022 4:02 PM]
09-05-2022	AH	4:00 PM ET (May 9)	OCUL	Ocular Therapeutix, Inc.	295.50	-0.22	-0.25	-0.24	Ocular Therapeutix GAAP EPS of -$0.22 beats by $0.03, revenue of $13.19M misses by $0.77M [5/9/2022 4:05 PM]	3.35	0.09 (2.79%)	3.25	-0.01 (-0.31%)	3.18 - 16.04	453,637	611,908	750
Ocular Therapeutix GAAP EPS of -$0.22 beats by $0.03, revenue of $13.19M misses by $0.77M [5/9/2022 4:05 PM] Ocular Therapeutix Reports First Quarter 2022 Financial Results and Business Update [May-09-22 04:01PM] Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates [May-09-22 05:45PM]
28-02-2022	AH	4:00 PM ET (Feb 28)	OCUL	Ocular Therapeutix, Inc.	404.50	-0.23	-0.23	-0.23	Ocular Therapeutix GAAP EPS of -$0.23 in-line, revenue of $12.31M misses by $2.13M [2/28/2022 4:03 PM]	5.50	-0.08 (-1.47%)	5.76	0.18 (3.23%)	4.71 - 21.48	485,115	680,000	4,034
Ocular Therapeutix GAAP EPS of -$0.23 in-line, revenue of $12.31M misses by $2.13M [2/28/2022 4:03 PM] Ocular Therapeutix Reports Fourth Quarter and Year-End 2021 Financial Results and Business Update [Feb-28-22 04:01PM] Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates [Feb-28-22 05:35PM]
08-11-2021	AH	4:00 PM ET (Nov 8)	OCUL	Ocular Therapeutix, Inc.	536.08	-0.23	-0.26	-0.17	Ocular Therapeutix EPS beats by $0.04, misses on revenue [11/8/2021 4:02 PM]	7.66	0.56 (7.89%)	6.99	-0.11 (-1.55%)	6.60 - 24.30	2,012,264	1,170,000	17,753
Ocular Therapeutix EPS beats by $0.04, misses on revenue [11/8/2021 4:02 PM] Could The Ocular Therapeutix, Inc. (NASDAQ:OCUL) Ownership Structure Tell Us Something Useful? [Nov-05-21 11:44AM] Ocular Therapeutix Announces Update from the Centers for Medicare and Medicaid Services (CMS) for the Reimbursement of DEXTENZA® [Nov-05-21 09:00AM] Ocular Therapeutix Reports Third Quarter 2021 Financial Results and Business Update [Nov-08-21 04:01PM] Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates [Nov-08-21 07:35PM] Ocular Therapeutix Announces Success in Patent Appeal Brought by Mati Therapeutics, Inc. [Nov-09-21 09:06AM] Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati [Nov-09-21 01:17PM]
09-08-2021	AH	4:00 PM ET (Aug 9)	OCUL	Ocular Therapeutix, Inc.	839.98	-0.25	-0.20	-0.34	Ocular Therapeutix EPS misses by $0.05, beats on revenue [8/9/2021 4:06 PM]	11.00	0.27 (2.55%)	11.50	0.77 (7.18%)	7.14 - 24.30	1,231,647	770,000	45,134
Ocular Therapeutix EPS misses by $0.05, beats on revenue [8/9/2021 4:06 PM] Ocular Therapeutix Reports Second Quarter 2021 Financial Results and Business Update [Aug-09-21 04:01PM] Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-21 05:25PM] Ocular Therapeutix to Present at the H.C. Wainwright Ophthalmology Virtual Conference [Aug-10-21 08:00AM]
05-05-2021	AH	4:00 PM ET (May 5)	OCUL	Ocular Therapeutix, Inc.	1,400	-0.24	-0.20	-0.41	Ocular Therapeutix EPS misses by $0.04, misses on revenue [5/5/2021 4:03 PM]	15.87	-0.69 (-4.17%)	15.87	0.0 (0.00%)	5.85 - 24.30	1,074,297	1,910,000	6,733
Ocular Therapeutix, Inc. to Host Earnings Call [May-05-21 02:30PM] Ocular Therapeutix Reports First Quarter 2021 Financial Results and Business Update [May-05-21 04:01PM]
11-03-2021	AH	4:00 PM ET (Mar 11)	OCUL	Ocular Therapeutix, Inc.	1,390	-0.23	-0.18	-0.47	Ocular Therapeutix EPS misses by $1.04, misses on revenue [3/11/2021 4:05 PM]	20.82	0.52 (2.54%)	18.81	-1.50 (-7.39%)	3.78 - 24.30	1,383,168	1,033,465	48,471
Ocular Therapeutix EPS misses by $1.04, misses on revenue [3/11/2021 4:05 PM] Ocular Therapeutix, Inc. to Host Earnings Call [Mar-11-21 02:30PM] Ocular Therapeutix Reports Fourth Quarter and Year End 2020 Financial Results and Business Update [Mar-11-21 04:01PM] Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates [Mar-11-21 05:25PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	OCUL	Ocular Therapeutix, Inc.	751.80	-0.17	-0.23	-0.45	Ocular Therapeutix EPS beats by $0.02, beats on revenue [11/5/2020 4:02 PM]	12.84	0.84 (7.00%)	12.19	0.19 (1.58%)	2.46 - 13.44	1,320,416	1,164,354	4,159

07-08-2020	PM	7:00 AM ET (Aug 7)	OCUL	Ocular Therapeutix, Inc.	531.69	-0.34	-0.31	-0.57	Ocular Therapeutix EPS misses by $0.32, misses on revenue [8/7/2020 7:17 AM]	8.65	0.19 (2.25%)	8.65	0.19 (2.25%)	2.46 - 9.27	433,466	479,268	4,727